The prices of Chinese herbal medicines continue to hibernate at the end of the year

The business club reported on December 10th that "even honeysuckle has risen to more than 300 yuan a pound, too exaggerated!" Recently, customers complained to the pharmacy staff in Guangzhou. And why do pharmacies don't have headaches? With the advent of the winter season, the price of Chinese herbal medicines has been bullish all year long, with higher-end gains at the end of the year. The Chinese medicine companies are also feeling cost pressures, and some companies have even stopped production of certain types of finished medicines. For this price rise frenzy, the upstream and terminal are currently waiting to be met.

Chinese herbal medicines rose rapidly

The wave of rising prices of the Pacific ginseng represented. Mr. Long from the Second Paradise Branch in Liwan District, Guangzhou, said that 70% of Chinese herbal medicines have gone up in price since the beginning of this year. For example, Taizishen had a purchase price of 30 yuan per kilogram last year and it has soared to about 330 yuan per kilogram. The increase was as much as 10 times.

In fact, this is only a microcosm, and the surge of Chinese herbal medicine prices has swept the country. According to a survey of pharmacies in Shaanxi, Shanghai, Fujian, Jiangxi, Guangdong, and Jiangsu provinces by pharmacy business weekly reporters, in October and November this year, many pharmacies have more than 10 prices of medicinal herbs (see the attached table for details).

According to relevant statistics, in the past year, 84% of the 537 kinds of Chinese herbal medicines on the national market have risen in price, and the rate of increase and frequency are rare. According to the data released by the Chinese Medicine Association's Chinese Herbal Material Information Center, from October 2009 to October 2010, Chinese herbal medicines with a market growth rate of 51% to 100% accounted for 28%; an increase of 21% to 50% and an increase of 101%. %~180% of Chinese herbal medicines accounted for 22%; Chinese herbal medicines, which rose 5% to 20%, accounted for 17%. Among them, Cordyceps sinensis ranked first on the list of rising prices, followed by leeches, pine nuts, green shells, donkey-hide gelatin, American ginseng, heterophylla, Panax pseudoginseng, and bovine yellow.

Seasonal Chinese medicine prices rise

Compared with Chinese herbal medicines, the prices of Chinese patent medicines are generally stable, but some Chinese patent medicines have risen in price.

Shanghai Ren Yun Shang North Sihai pharmacy official said that the prices of many Chinese patent medicines in its stores have risen. Among them, Dongtian Changchun cream has seen the largest increase, which has caused customers to see only sales, and sales have declined. Jiangxi Nanchang Happy People Pharmacy It also stated that the price of Danshen tablets in its stores has risen by 50%. Due to the rapid inventory update, there are more Chinese patent medicines affected by the price increase of raw materials, and the opinions of customers are relatively large. Fortunately, sales are basically the same.

The relevant person in charge of the Shanghai Yutian Tang drug number believes that the price increase is mainly concentrated on nourishing Chinese herbal medicines, but on the whole, it has not yet had a significant impact on the market, especially Chinese patent medicines have a hysteresis effect. It is necessary to digest stocks first, and the impact may be more obvious in the next year.

Insiders pointed out that at present, the ex-factory prices of certain Chinese patent medicines obtained by pharmacies from pharmaceutical distribution companies have indeed increased, but overall, the rate of increase is not high, mostly between 2% and 3%. Larger but also 5% to 10%, and most of the season Chinese medicines, such as Shuanghuanglian oral liquid, cold heat particles, gold wolfberry fruit and so on.

Some of the finished product varieties have been discontinued

When the terminal and consumers have frequently criticized this wave of price increases, the cost has risen steadily. Upstream manufacturers are also feeling cost pressures.

Shenwei Pharmaceutical official said that since the beginning of this year, the average price of Chinese herbal medicines purchased has increased compared with the same period of 2009, and prices of more than 85% of Chinese herbal medicines have risen sharply. For example, the price of Banlangen, the main Raw Material for many products, has doubled. The price of Qianhu rose by more than 100%. The prices of major medicinal materials such as honeysuckle, Pinellia, Bitter Almond, Chuanxiong, Huangqi, Ophiopogon, Atractylodes, Red Ginseng, and Buffalo horn all increased significantly.

Tang Liangping, president of the Chongqing Pharmaceutical Chamber of Commerce, said that after rising prices, companies that produce plasters are the first to bear the brunt, followed by companies that produce proprietary Chinese and western medicines. At present, 80% of the companies that make plaster products on the market are earning money at a loss.

However, even so, drug companies are under various pressures to dare to raise prices. In addition to frequent national price cuts and price cuts, the company’s assistant to Huang Weiwen, a vice president of Jiangxi Youth Culture Group Co., Ltd., broke down its reason: “In a highly competitive Chinese medicine market, there is no competitive advantage at a price increase. In general, Enterprises will not easily use this last resort, but will use other channels to absorb the pressure of Chinese herbal medicines' price increases." He said that some companies have stopped production of some varieties, these products are generally not the mainstream manufacturers, but their production Costs and sales prices are upside down, and the more they lose more than their production, it is better to focus on the main varieties.

In response, many pharmacy people said that the current price increase, the terminal initiative to obtain cooperation with the upstream is the top priority. Fujian Huihao Four Seas Co., Ltd. actively shares the performance of Chinese herbal medicines in the terminal with the upstream manufacturers, and keeps track of the price information of Chinese herbal medicines in Quzhou. It strives to prepare stocks before the market price rises. The relevant person in charge of the Shanghai Yutiantang Medicines said: “The linkage between production and sales is the most important. Effective methods, and in the long run, establishing a unified Chinese herbal medicine industry standard or building a national herbal medicine exchange is the fundamental solution to the problem."

Our Anti-cancer & Anti-Tumor Ingredient ingredient supplier Organic Herb Inc`s range of products include: Polygonum Cuspidatum Extract Resveratrol,Tomato extract lycopene, Smoke Tree Extract Fisetin, Milk Thistle Extract (Silymarin, Silybins), Bilberry Extract Anthocyanidins, Tripterygium wilfordii extract (Celastrol), usnic acid, oxymatrine, Tanshinone IIA, Osthole, Charantin etc.

There are many plant extract supplements may help to treat cancer which cause about 14.6% or more of human death .Some of the ingredients such as Curcuminare found to be more effective than chemotherapy as they kill cancer cells without harming healthy cell .Some other components may help to rebuilt the patient`s immune system or ease side effects of chemotherapy and radiation .Anticancer research showed the promising application of a wide rang of natural plant extracts chemical components as anticancer agents .A China-based plant extract manufacturer Organic Herb Inc is committed to producing ,developing and exploring the Anti-cancer & Anti-tumor Ingredient with best quality .

Anti-cancer & Anti-tumor Ingredient

Anti-Cancer Ingredient,Anti-Tumor Ingredient,Tomato Extract Powder,Anti-Cancer Herb Ingredient

Organic Herb Inc. ,